# Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

> **NCT03643887** · PHASE2 · WITHDRAWN · sponsor: **University of Wisconsin, Madison**

## Conditions studied

- Clostridium Difficile Infection

## Interventions

- **DRUG:** FMT Capsule DE
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03643887
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2025-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding obtained
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03643887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03643887, "Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03643887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*